Literature DB >> 15308566

Epinephrine acts through erythroid signaling pathways to activate sickle cell adhesion to endothelium via LW-alphavbeta3 interactions.

Rahima Zennadi1, Patrick C Hines, Laura M De Castro, Jean-Pierre Cartron, Leslie V Parise, Marilyn J Telen.   

Abstract

The possible role of physiologic stress hormones in enhancing adhesion of sickle erythrocytes (SS RBCs) to endothelial cells (ECs) in sickle cell disease (SCD) has not been previously explored. We have now found that up-regulation of intracellular cyclic adenosine monophosphate (cAMP)-dependent protein kinase A (PKA) by epinephrine significantly increased sickle but not normal erythrocyte adhesion to both primary and immortalized ECs. Inhibition of serine/threonine phosphatases also enhanced sickle erythrocyte adhesion at least partially through a PKA-dependent mechanism. Adhesion was mediated through LW (intercellular adhesion molecule-4 [ICAM-4], CD242) blood group glycoprotein, and immunoprecipitation studies showed that LW on sickle but not on normal erythrocytes undergoes increased PKA-dependent serine phosphorylation as a result of activation. The major counter receptor for LW was identified as the alphavbeta3 integrin on ECs. These data suggest that adrenergic hormones such as epinephrine may initiate or exacerbate vaso-occlusion and thus contribute to the association of vaso-occlusive events with physiologic stress.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15308566     DOI: 10.1182/blood-2004-01-0042

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  45 in total

1.  Erythrocyte plasma membrane-bound ERK1/2 activation promotes ICAM-4-mediated sickle red cell adhesion to endothelium.

Authors:  Rahima Zennadi; Erin J Whalen; Erik J Soderblom; Susan C Alexander; J Will Thompson; Laura G Dubois; M Arthur Moseley; Marilyn J Telen
Journal:  Blood       Date:  2011-12-06       Impact factor: 22.113

2.  Epinephrine modulates BCAM/Lu and ICAM-4 expression on the sickle cell trait red blood cell membrane.

Authors:  Jamie L Maciaszek; Biree Andemariam; Greg Huber; George Lykotrafitis
Journal:  Biophys J       Date:  2012-03-06       Impact factor: 4.033

Review 3.  Beyond hydroxyurea: new and old drugs in the pipeline for sickle cell disease.

Authors:  Marilyn J Telen
Journal:  Blood       Date:  2016-01-12       Impact factor: 22.113

Review 4.  Redox-dependent impairment of vascular function in sickle cell disease.

Authors:  Mutay Aslan; Bruce A Freeman
Journal:  Free Radic Biol Med       Date:  2007-08-31       Impact factor: 7.376

5.  AKAP-dependent modulation of BCAM/Lu adhesion on normal and sickle cell disease RBCs revealed by force nanoscopy.

Authors:  Jamie L Maciaszek; Biree Andemariam; Krithika Abiraman; George Lykotrafitis
Journal:  Biophys J       Date:  2014-03-18       Impact factor: 4.033

6.  Effect of propranolol as antiadhesive therapy in sickle cell disease.

Authors:  Laura M De Castro; Rahima Zennadi; Jude C Jonassaint; Milena Batchvarova; Marilyn J Telen
Journal:  Clin Transl Sci       Date:  2012-10-17       Impact factor: 4.689

7.  Intercellular adhesion molecule-4 and CD36 are implicated in the abnormal adhesiveness of sickle cell SAD mouse erythrocytes to endothelium.

Authors:  Marie-Marcelle Trinh-Trang-Tan; Camilo Vilela-Lamego; Julien Picot; Marie-Paule Wautier; Jean-Pierre Cartron
Journal:  Haematologica       Date:  2009-12-16       Impact factor: 9.941

8.  Sickle red cells induce adhesion of lymphocytes and monocytes to endothelium.

Authors:  Rahima Zennadi; Ai Chien; Ke Xu; Milena Batchvarova; Marilyn J Telen
Journal:  Blood       Date:  2008-07-29       Impact factor: 22.113

9.  Genetic diminution of circulating prothrombin ameliorates multiorgan pathologies in sickle cell disease mice.

Authors:  Paritha I Arumugam; Eric S Mullins; Shiva Kumar Shanmukhappa; Brett P Monia; Anastacia Loberg; Maureen A Shaw; Tilat Rizvi; Janaka Wansapura; Jay L Degen; Punam Malik
Journal:  Blood       Date:  2015-08-18       Impact factor: 22.113

10.  Sickle Cell Disease in the Post Genomic Era: A Monogenic Disease with a Polygenic Phenotype.

Authors:  A Driss; K O Asare; J M Hibbert; B E Gee; T V Adamkiewicz; J K Stiles
Journal:  Genomics Insights       Date:  2009-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.